Package Insert: Information for the Patient
Rocoz100 mgCoated Tablets EFG
Quetiapine
Read this package insert carefully before starting to take this medication,because it contains important information for you.
Rocoz contains a substance called quetiapine. It belongs to a group of medications called antipsychotics.Quetiapinecan be used to treat various diseases, such as:
Your doctor may continue prescribing youquetiapineeven when you are feeling better.
If you are unsure, consult your doctor or pharmacist before taking this medication.
Warnings and precautions
Consult your doctor or pharmacist before starting to takeRocoz:
Inform your doctor immediately if after taking this medication you experience any of the following::
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to be effective, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information obtained from clinical trials has shown an increased risk of suicidal thoughts and/or behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Taking Rocoz with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take quetiapine if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Rocoz with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. Do not take quetiapine during pregnancy, unless you have consulted your doctor. Do not use quetiapine if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremors, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
This medication may cause drowsiness. Do not drive or operate tools or machinery until you know how the medication affects you.
Rocoz contains lactose
This medication contains lactose. If your doctor has told you that you have a lactose intolerance, consult with them before taking this medication.
Effect on Drug Detection Tests in Urine
If you are undergoing a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but it will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapineshould not be used in children and adolescents under 18 years of age.
If you take more Rocoz than you should
If you take more quetiapine than your doctor prescribed, you mayfeel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your quetiapine tablets with you. You can also call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rocoz
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Rocoz
If you stop takingquetiapineabruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Very rare:may affect up to 1 in 10,000 people
Unknown: the frequency cannot be estimated from available data
The class of medicines to which quetiapine belongs may cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofRocoz
The active ingredient is quetiapine. Each tablet contains 100 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: Lactose monohydrate, microcrystalline cellulose, calcium dihydroxide phosphate, povidone K30, sodium carboxymethylcellulose (Type A) from potato and calcium stearate.
Tablet coating: Hypromellose, titanium dioxide (E171) and triacetin.
Appearance of the product and contents of the packaging
The tablets are white, biconvex, and round.
They are presented in white opaque PVC blisters and aluminum, in packs of 60 tablets.
Holder of the marketing authorization and responsible manufacturer
Laboratorios Alter, S.A.
C/ Mateo Inurria, 30
28036 Madrid
Spain
or
Laboratorios Alter, S.A.
C/ Zeus, 6
Polígono Industrial R2
28880 Meco (Madrid)
Spain
Last review date of this leaflet: June 2024
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.